Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Production. Per the activity note to the FY2024 annual report, the company manufactures pharmaceutical products and provides healthcare-related services. Founded in 2016.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 280 | 322 | 596 | 1,142 | 743 | 581 | 398 | +6.1% |
| Net Cash used in Investing Activities | 152 | 22 | 183 | 187 | 319 | 28 | 68 | -12.5% |
| Free Cash Flow (OCF − Capex proxy) | 128 | 300 | 413 | 955 | 423 | 553 | 330 | +17.1% |
| Net Cash from Financing Activities | 1 | 191 | 124 | 211 | 481 | 659 | 766 | nmf |
| Net Change in Cash (before FX) | 128 | 109 | 289 | 744 | 58 | 106 | 436 | nmf |
| Effect of FX on Cash | 0 | 1 | 20 | 9 | 110 | 9 | 5 | nmf |
| Net Change in Cash (incl. FX) | 128 | 109 | 309 | 735 | 167 | 116 | 431 | nmf |
| Cash at Beginning of Year | 71 | 199 | 308 | 617 | 1,352 | 1,185 | 1,069 | +57.0% |
| Cash at End of Year | 199 | 308 | 617 | 1,352 | 1,185 | 1,069 | 638 | +21.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →